Patent · US Active

Co-crystals of SGLT2 inhibitors, process for their preparation and pharmaceutical compositions thereof

US11040961B2 · kind B2 · utility

0Cited by
15References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 2, 2019
Grant dateJun 22, 2021
Priority date
Expiry dateAug 19, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D407/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides solid forms of SGLT2 inhibitors, to processes for their preparation and their use in the purification of SGLT2 inhibitors and also provided pharmaceutical compositions comprising them and their use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.